Trial intelligence / Profile preview

Ramipril vs Irbesartan for Left Atrial Remodelling in Hypertension

NCT00517322Phase 4Unknown

Sponsor
University of Insubria
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ramipril, irbesartan in essential hypertension, sponsored by University of Insubria. Status: unknown.

02

Drugs

ramiprilirbesartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00517322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00517322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call